90 related articles for article (PubMed ID: 9852401)
1. Requirement of estrogen receptor expression and function for [12Val] K-Ras-mediated NIH3T3 cell transformation.
Kato K; Sakamoto T; Wake N
Oncology; 1998 Dec; 55 Suppl 1():45-52. PubMed ID: 9852401
[TBL] [Abstract][Full Text] [Related]
2. Contribution of enhanced transcriptional activation by ER to [12Val] K-Ras mediated NIH3T3 cell transformation.
Kato K; Ueoka Y; Kato K; Hachiya T; Nishida J; Wake N
Oncogene; 1997 Dec; 15(25):3037-46. PubMed ID: 9444952
[TBL] [Abstract][Full Text] [Related]
3. Tumorigenesis of K-ras mutation in human endometrial carcinoma via upregulation of estrogen receptor.
Tu Z; Gui L; Wang J; Li X; Sun P; Wei L
Gynecol Oncol; 2006 May; 101(2):274-9. PubMed ID: 16303170
[TBL] [Abstract][Full Text] [Related]
4. [Regulation of [12Asp]K-ras4B on transcriptional activity of estrogen receptor in endometrial carcinoma HEC-1A cell lines].
Gui LM; Wei LH; Xu MX; Wang JL; Zhong YC; Li XP; Tu Z; Sun PM; Ma DL
Zhonghua Fu Chan Ke Za Zhi; 2004 Jan; 39(1):30-4. PubMed ID: 14989985
[TBL] [Abstract][Full Text] [Related]
5. Relevance of ER to the Development of Endometrial Hyperplasia and Adenocarcinoma.
Kato K; Horiuchi S; Terao Y; Ueoka Y; Nishida Ji; Mori D; Yoshikawa Y; Wake N
Breast Cancer; 1999 Oct; 6(4):312-319. PubMed ID: 11091736
[TBL] [Abstract][Full Text] [Related]
6. Contribution of estrogen receptor alpha to oncogenic K-Ras-mediated NIH3T3 cell transformation and its implication for escape from senescence by modulating the p53 pathway.
Kato K; Horiuchi S; Takahashi A; Ueoka Y; Arima T; Matsuda T; Kato H; Nishida Ji J; Nakabeppu Y; Wake N
J Biol Chem; 2002 Mar; 277(13):11217-24. PubMed ID: 11781307
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Bhat KP; Pezzuto JM
Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
[TBL] [Abstract][Full Text] [Related]
8. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor.
Migliaccio A; Piccolo D; Castoria G; Di Domenico M; Bilancio A; Lombardi M; Gong W; Beato M; Auricchio F
EMBO J; 1998 Apr; 17(7):2008-18. PubMed ID: 9524123
[TBL] [Abstract][Full Text] [Related]
9. Pathology of Endometrial Carcinoma.
Lax SF
Adv Exp Med Biol; 2017; 943():75-96. PubMed ID: 27910065
[TBL] [Abstract][Full Text] [Related]
10. MTH1 expression is required for effective transformation by oncogenic HRAS.
Giribaldi MG; Munoz A; Halvorsen K; Patel A; Rai P
Oncotarget; 2015 May; 6(13):11519-29. PubMed ID: 25893378
[TBL] [Abstract][Full Text] [Related]
11. Regulator of G protein signaling 19 suppresses Ras-induced neoplastic transformation and tumorigenesis.
Wang Y; Tong Y; Tso PH; Wong YH
Cancer Lett; 2013 Oct; 339(1):33-41. PubMed ID: 23911936
[TBL] [Abstract][Full Text] [Related]
12. Estrogen induces c-Ha-ras expression via activation of tyrosine kinase in uterine endometrial fibroblasts and cancer cells.
Fujimoto J; Ichigo S; Hori M; Morishita S; Tamaya T
J Steroid Biochem Mol Biol; 1995 Oct; 55(1):25-33. PubMed ID: 7577718
[TBL] [Abstract][Full Text] [Related]
13. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
[TBL] [Abstract][Full Text] [Related]
14. K-Ras stabilization by estrogen via PKCδ is involved in endometrial tumorigenesis.
Koo KH; Jeong WJ; Cho YH; Park JC; Min do S; Choi KY
Oncotarget; 2015 Aug; 6(25):21328-40. PubMed ID: 26015399
[TBL] [Abstract][Full Text] [Related]
15. Ets1 was significantly activated by ERK1/2 in mutant K-ras stably transfected human adrenocortical cells.
Chen YF; Shin SJ; Lin SR
DNA Cell Biol; 2005 Feb; 24(2):126-32. PubMed ID: 15699632
[TBL] [Abstract][Full Text] [Related]
16. An inhibitory effect on cell proliferation by blockage of the MAPK/estrogen receptor/MDM2 signal pathway in gynecologic cancer.
Suga S; Kato K; Ohgami T; Yamayoshi A; Adachi S; Asanoma K; Yamaguchi S; Arima T; Kinoshita K; Wake N
Gynecol Oncol; 2007 May; 105(2):341-50. PubMed ID: 17306348
[TBL] [Abstract][Full Text] [Related]
17. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of endometrial carcinoma cell growth using antisense estrogen receptor oligodeoxyribonucleotides.
Taylor AH; al-Azzawi F; Pringle JH; Bell SC
Anticancer Res; 2002; 22(6C):3993-4003. PubMed ID: 12553024
[TBL] [Abstract][Full Text] [Related]
19. K-ras mutation in tamoxifen-related endometrial polyps.
Hachisuga T; Miyakawa T; Tsujioka H; Horiuchi S; Emoto M; Kawarabayashi T
Cancer; 2003 Nov; 98(9):1890-7. PubMed ID: 14584071
[TBL] [Abstract][Full Text] [Related]
20. Loss of an estrogen receptor isoform (ER alpha delta 3) in breast cancer and the consequences of its reexpression: interference with estrogen-stimulated properties of malignant transformation.
Erenburg I; Schachter B; Mira y Lopez R; Ossowski L
Mol Endocrinol; 1997 Dec; 11(13):2004-15. PubMed ID: 9415404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
